3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Head and Neck Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neurotoxicity Syndromes
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Glioma
1
Cytokine Release Syndrome
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
fludarabine
2
Cyclophosphamide
2
zanubrutinib
1
pegfilgrastim
1
obinutuzumab
1
fludarabine phosphate
1
Specimen Handling
1
Resistance Training
1
Radiotherapy
1
Neuropsychological Tests
1
Modafinil
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Injections
1
Filgrastim
1
Contrast Media
1
Blood Specimen Collection
1
Azacitidine
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma, B-Cell
×
Contrast Media
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled